Zimmer Biomet Hl Rg
ZBH
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
06/30/2025 - 22:15:00
Bid
06/30/2025 - 21:59:59
Bid
Volume
Ask
06/30/2025 - 21:59:59
Ask
Volume
91.21
-0.25 ( -0.27% )
91.18
3,100
91.19
9,200
More information
Analysis by TheScreener
27.06.2025
Evaluation Neutral  
Interest Very weak  
Sensibility Middle  
Analysis date: 27.06.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 27.05.2025.
Interest
  Very weak
One star since 09.05.2025.
Earnings Rev Trend
  -0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 06.05.2025 at a price of 92.27.
Evaluation
  Neutral
 
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
  Negative
 
The forty day technical trend is negative since 08.04.2025.
4wk Rel Perf
  -6.91%
 
The four-week dividend-adjusted underperformance versus SP500 is 6.91%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 27.05.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.66%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.54%.
Mkt Cap in $bn
  18.10
With a market capitalization >$8bn, ZIMMER BIOMET is considered a large-cap stock.
G/PE Ratio
  0.84
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  10.61
The estimated PE is for the year 2027.
LT Growth
  7.86%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  23
Over the last seven weeks, an average of 23 analysts provided earnings per share estimates.
Dividend Yield
  1.08%
The twelve month estimated dividend yield represents 11.41% of earnings forecasts.
Beta
  32
For 1% of index variation, the stock varies on average by 0.32%.
Correlation
  0.26
Stock movements are strongly independent of index variations.
Value at Risk
  13.67
The value at risk is estimated at USD 13.67. The risk is therefore 14.94%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  24.07.2002